Equity Details
Price & Market Data
Price: $0.625
Daily Change: +$0.0572 / 9.15%
Daily Range: $0.532 - $0.645
Market Cap: $21,269,406
Daily Volume: 2,787,247
Performance Metrics
1 Week: 23.93%
1 Month: 19.06%
3 Months: 24.68%
6 Months: 6.98%
1 Year: -48.63%
YTD: 13.83%
About OSR Holdings, Inc. (OSRH)
Market summary for OSR Holdings, Inc. (OSRH). Price: 0.625, daily change: +$0.0572 / 9.15%. Market cap: 21,269,406. Performance YTD, 1-month, 3-month.
Company Details
Employees: 4
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.